Dignitana board member William Cronin resigns

Files for download
Dignitana Release - wkr0006.pdf

Dignitana AB announces that William Cronin, Deputy Chairman of the Board, has resigned from the Board of Directors. Citing personal reasons, his resignation takes effect 24 June 2024.

“On behalf of the Board, I would like to thank William for his many years of service to Dignitana, both as a board member and previously as CEO. His contributions to the company are significant, and we wish him all the best in his future endeavors,” comments Klas Arildsson, Chairman of the Board.

For More Information Contact 

Klas Arildsson, Chairman of the Board of Directors, klas.arildsson@dignitana.com

Melissa Bourestom, Chief Communications Officer,  melissa.bourestom@dignitana.com  +1 469-518-5031

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com